Human Alternative Complement Pathway-Mediated Lysis of Rabbit Erythrocytes Is Enhanced by Natural Anti-Galα1-3Gal Antibodies

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5606-5609

  Tomlinson, Stephen ^a   Nussenzweig, Victor ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GLYCOSPHINGOLIPID;

ANIMAL; ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; ERYTHROCYTE; HEMOLYSIS; HUMAN; IMMUNOLOGY; PHYSIOLOGY; RABBIT;

ANIMALS; ANTIBODIES; COMPLEMENT PATHWAY, ALTERNATIVE; ERYTHROCYTES; GLYCOSPHINGOLIPIDS; HEMOLYSIS; HUMANS; RABBITS;

EID: 0031301832     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Galili, U., B. A. Macher, J. Buehler, and S. B. Shohet. 1985. Human natural anti-alpha-galactosyl IgG: specific recognition of alpha(1-3)-linked galactose residues. J. Exp. Med. 162:573.
2. Parker, W., D. Bruno, Z. E. Holzknecht, and J. L. Platt. 1994. Characterization and affinity isolation of xenoreactive natural antibodies. J. Immunol. 153:3791.
3. Sandrin, M. S., H. A. Vauhan, P. L. Dabkowski, and I. F. C. McKenzie. 1993. Anti-pig IgM antibodies in human serum react predominantly with gal(alpha-1-3)gal epitopes. Proc. Natl. Acad. Sci. USA 90:11391.
4. Galili, U., and K. Swanson. 1991. Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc. Natl. Acad. Sci. USA 88:7401.
5. Galili, U., S. B. Shohet, E. Kobrin, C. L. Stults, and B. A. Machler. 1988. Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J. Biol. Chem. 263:17755.
6. Sacks, D. H., and F. H. Bach. 1990. Immunology of xenograph rejection. Hum. Immunol. 28:245.
7. Parker, W., S. Saadi, S. S. Lin, Z. E. Holzknecht, M. Bustos, and J. E. Platt. 1996. Transplantation of discordant xenografts: a challenge revisited. Immunol. Today 17:373.
8. Squinto, S. P. 1996. Xenogeneic organ transplantation. Curr. Opin. Biotechnol. 7:641.
9. Galili, U. 1993. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-gal) antibody. Springer Semin. Immunopathol. 15:155.
10. Rother, R. P., W. L. Fodor, J. P. Springhorn, C. W. Birks, E. Setter, M. S. Sandrin, S. P. Squinto, and S. A. Rollins. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J. Exp. Med. 182:1345.
11. Hamadeh, R. M., G. A. Jarvis, U. Galili, R. E. Mandrell, P. Zhou, and J. M. Griffiss. 1992. Human natural anti-gal IgG regulates alternative complement pathway activation on bacterial surfaces. J. Clin. Invest. 89:1223.
12. Avila, J. L., M. Rojas, and U. Galili. 1989. Immunogenic gal-α1-3gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J Immunol. 142:2828.
13. Almeida, I. C., S. R. Milani, P. A. Gorin, and L. R. Travassos. 1991. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-α-galactosyl antibodies. J. Immunol. 146:2394.
14. Platts-Mills, T. A. E., and K. Ishizaka. 1974. Activation of the alternative pathway of human complement by rabbit cells. J. Immunol. 113:348.
15. Fearon, D. T., and K. F. Austen. 1978. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. J. Exp. Med. 146:22.
16. Ratnoff, W. D., D. T. Fearon, and K. F. Austen. 1983. The role of antibody in the activation of the alternative complement pathway. Springer Semin. Immunopathol. 6:361.
17. Nelson, B., and S. Ruddy. 1979. Enhancing role of IgG in lysis of rabbit erythrocytes by the alternative pathway of human complement. J. Immunol. 122:1994.
18. Polhill, R. B., S. L. Newman, K. M. Pruitt, and R. B. Johnston. 1978. Kinetic assessment of alternative complement pathway activity in a hemolytic system. II. Influence of antibody on alternative pathway activation. J. Immunol. 121:371.
19. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
20. Grant, J. 1978. Immunological Methods in Bacteriology. Blackwell, Oxford.
21. Yu, P. B., Z. E. Holzknecht, D. Bruno, W. Parker, and J. L. Platt. 1996. Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-gal α1-3gal antibodies. J. Immunol. 157:5163.
22. Fries, L. F., T. A. Gaitner, C. H. Hammer, and M. M. Frank. 1984. C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I. J. Exp. Med. 160:1640.
23. Diaz, A., A. Ferreira, and R. B. Sim. 1997. Complement evasion by Echinococcus granulosus. J. Immunol. 158:3779.
24. Horstmann, R. D. 1992. Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement. Infect. Immun. 60:721.
25. Stoiber, H., C. Pinter, A. C. Siccardi, A. Clivio, and M. P. Dierich. 1996. Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. 183:307.
26. China, B., M. P. Sory, B. T. N'Guyen, M. Bruyere, and G. R. Cornelis. 1993. Role of the YadA protein in prevention of opsonization of Yersinia enterolytica by C3b molecules. Infect. Immun. 61:3129.
27. Meri, S., and M. K. Pangburn. 1990. Discrimination between activators and non-activators of the alternative pathway of complement: regulation via a sialic acid/ polyanion binding site on factor H. Proc. Natl. Acad. Sci. USA 87:3982.
28. Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell bound C3b. J. Immunol. 122:75.
29. Pangburn, M. K., and H. J. Mueller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase treated cells. Proc. Natl. Acad. Sci. USA 75:2416.
30. Fearon, D. T. 1978. Regulation by membrane sialic acid of β1H-dependent decay dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA 75:1971.
31. Pangburn, M. K., D. C. Morrison, R. D. Schreiber, and H. J. Mueller-Eberhard. 1980. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b. J. Immunol. 124:977.
32. Platt, J. L., R. J. Fischel, A. J. Matas, S. A. Reif, R. M. Bolman, and F. H. Bach. 1991. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 52:214.
33. Collins, B. H., A. H. Cotterell, K. R. McCurry, C. G. Alvarado, J. C. Magee, W. Parker, and J. L. Platt. 1995. Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl determinant in hyperacute rejection. J. Immunol. 154:5500.
34. Magee, J. C., B. H. Collins, R. C. Harland, B. J. Lindman, R. R. Bollinger, M. M. Frank, and J. L. Platt. 1995. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J. Clin. Invest. 96:2404.
35. Oliveira, T. G., S. R. Milani, and L. R. Travassos. 1996. Polyclonal B-cell activation by Neisseria meningitidis capsular polysaccharide elicits antibodies protective against Trypanosoma cruzi infection in vitro. J. Clin. Lab. Anal. 10:220.